As managing editor of PCMag's security team, it's my responsibility to ensure that our product advice is evidence-based, ...
PCMag on MSN
The passphrase method: The simple trick to creating unhackable passwords you’ll actually remember
Tired of forgetting passwords or reusing weak ones? The passphrase approach makes strong security easy to remember—and harder ...
We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...
If you’re already using AI for everything from crafting tone-appropriate emails to finding a skincare routine that works, using a chatbot to generate passwords for you probably seems like a good idea.
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...
The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...
Facepalm: As we continue waiting for it to find a cure for cancer, it seems there's something else that AI isn't very good at: generating passwords. New research suggests that asking large language ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results